HEALTHSCIENCE DAILY
Ozempic delivers major weight loss in adults over 65, study finds
Semaglutide, also known as Ozempic and Wegovy, has been found to be highly effective in achieving significant weight loss in adults over 65, with participants losing an average of over 15% of their body weight and improving heart and metabolic health. This is a substantial improvement compared to placebo treatment. The study highlights the potential of semaglutide in helping older adults reach healthier weight levels.